Cargando…

The G-Protein Coupled Estrogen Receptor (GPER/GPR30) is a Gonadotropin Receptor Dependent Positive Prognosticator in Ovarian Carcinoma Patients

Follicle stimulating hormone receptor (FSHR) and luteinizing hormone receptor (LHCGR) were demonstrated to impact upon survival of patients suffering from epithelial ovarian cancer (EOC). Though structure wise the G-protein coupled estrogen receptor (GPER/GPR30) is related to FSHR/LHCGR, its prognos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heublein, Sabine, Mayr, Doris, Vrekoussis, Thomas, Friese, Klaus, Hofmann, Simone S., Jeschke, Udo, Lenhard, Miriam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3739730/ https://www.ncbi.nlm.nih.gov/pubmed/23951246 http://dx.doi.org/10.1371/journal.pone.0071791

Ejemplares similares

The G-Protein-Coupled Estrogen Receptor (GPER/GPR30) in Ovarian Granulosa Cell Tumors
por: Heublein, Sabine, et al.
Publicado: (2014)

Her-2/neu expression is a negative prognosticator in ovarian cancer cases that do not express the follicle stimulating hormone receptor (FSHR)
por: Heublein, Sabine, et al.
Publicado: (2013)

Steroid hormone receptor expression in ovarian cancer: progesterone receptor B as prognostic marker for patient survival
por: Lenhard, Miriam, et al.
Publicado: (2012)

Immunosuppressive Glycodelin A is an independent marker for poor prognosis in endometrial cancer
por: Lenhard, Miriam, et al.
Publicado: (2013)

The G-Protein-Coupled Estrogen Receptor (GPER) Regulates Trimethylation of Histone H3 at Lysine 4 and Represses Migration and Proliferation of Ovarian Cancer Cells In Vitro
por: Han, Nan, et al.
Publicado: (2021)

G-protein Coupled Estrogen Receptor (GPER/GPR30) and Women's Health
por: Kim, Mi-Jin, et al.
Publicado: (2015)

Glycodelin A is a prognostic marker to predict poor outcome in advanced stage ovarian cancer patients
por: Scholz, Christoph, et al.
Publicado: (2012)

Enhanced expression of G-protein coupled estrogen receptor (GPER/GPR30) in lung cancer
por: Jala, Venkatakrishna Rao, et al.
Publicado: (2012)

Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancer
por: Lenhard, Miriam, et al.
Publicado: (2012)

The G protein-coupled estrogen receptor 1 (GPER/GPR30) does not predict survival in patients with ovarian cancer
por: Kolkova, Zuzana, et al.
Publicado: (2012)

Expression and Role of the G Protein-Coupled Estrogen Receptor (GPR30/GPER) in the Development and Immune Response in Female Reproductive Cancers
por: Hernández-Silva, Christian David, et al.
Publicado: (2020)

Potential Interplay of the Gatipotuzumab Epitope TA-MUC1 and Estrogen Receptors in Ovarian Cancer
por: Heublein, Sabine, et al.
Publicado: (2019)

G Protein-Coupled Estrogen Receptor Correlates With Dkk2 Expression and Has Prognostic Impact in Ovarian Cancer Patients
por: Fraungruber, Patricia, et al.
Publicado: (2021)

Genetic Variants of GPER/GPR30, a Novel Estrogen-Related G Protein Receptor, Are Associated with Human Seminoma
por: Chevalier, Nicolas, et al.
Publicado: (2014)

Synthesis and Characterization of Tricarbonyl-Re/Tc(I) Chelate Probes Targeting the G Protein-Coupled Estrogen Receptor GPER/GPR30
por: Burai, Ritwik, et al.
Publicado: (2012)

Vitamin D receptor, Retinoid X receptor and peroxisome proliferator-activated receptor γ are overexpressed in BRCA1 mutated breast cancer and predict prognosis
por: Heublein, Sabine, et al.
Publicado: (2017)

Plasma membrane expression of G protein-coupled estrogen receptor (GPER)/G protein-coupled receptor 30 (GPR30) is associated with worse outcome in metachronous contralateral breast cancer
por: Tutzauer, Julia, et al.
Publicado: (2020)

Analysis of Epithelial Growth Factor-Receptor (EGFR) Phosphorylation in Uterine Smooth Muscle Tumors: Correlation to Mucin-1 and Galectin-3 Expression
por: Weissenbacher, Tobias, et al.
Publicado: (2013)

Thyroid Hormone Receptors Predict Prognosis in BRCA1 Associated Breast Cancer in Opposing Ways
por: Heublein, Sabine, et al.
Publicado: (2015)

KRAS, BRAF genotyping reveals genetic heterogeneity of ovarian borderline tumors and associated implants
por: Heublein, Sabine, et al.
Publicado: (2013)

Targeting the G protein-coupled estrogen receptor (GPER) in obesity and diabetes
por: Sharma, Geetanjali, et al.
Publicado: (2021)

Decidual Macrophages Are Significantly Increased in Spontaneous Miscarriages and Over-Express FasL: A Potential Role for Macrophages in Trophoblast Apoptosis
por: Guenther, Sabine, et al.
Publicado: (2012)

GPER: An Estrogen Receptor Key in Metastasis and Tumoral Microenvironments
por: Tirado-Garibay, Ana Carolina, et al.
Publicado: (2023)

17β-Estradiol on the Expression of G-Protein Coupled Estrogen Receptor (GPER/GPR30) Mitophagy, and the PI3K/Akt Signaling Pathway in ATDC5 Chondrocytes In Vitro
por: Fan, Dong-xiao, et al.
Publicado: (2018)

Estrogen-mediated inactivation of FOXO3a by the G protein-coupled estrogen receptor GPER
por: Zekas, Erin, et al.
Publicado: (2015)

Therapeutic Perspectives on the Modulation of G-Protein Coupled Estrogen Receptor, GPER, Function
por: Rouhimoghadam, Milad, et al.
Publicado: (2020)

The Role of G Protein-Coupled Estrogen Receptor (GPER) in Vascular Pathology and Physiology
por: Xu, Fujie, et al.
Publicado: (2023)

Reconsidering the roles of endogenous estrogens and xenoestrogens: the membrane estradiol receptor G protein-coupled receptor 30 (GPR30) mediates the effects of various estrogens
por: KADOKAWA, Hiroya, et al.
Publicado: (2018)

Nuclear receptor co-repressor NCOR2 and its relation to GPER with prognostic impact in ovarian cancer
por: Reichenbach, Juliane, et al.
Publicado: (2023)

The Cell Surface Estrogen Receptor, G Protein- Coupled Receptor 30 (GPR30), is Markedly Down Regulated During Breast Tumorigenesis
por: Poola, Indira, et al.
Publicado: (2008)

Does GPER Really Function as a G Protein-Coupled Estrogen Receptor in vivo?
por: Luo, Jing, et al.
Publicado: (2020)

The G Protein-Coupled Estrogen Receptor (GPER): A Critical Therapeutic Target for Cancer
por: Hall, Keith A., et al.
Publicado: (2023)

Subcellular Distribution of Thyroid Hormone Receptor Beta in Ovarian Cancer
por: Heublein, Sabine, et al.
Publicado: (2022)

Characterisation of Signalling by the Endogenous GPER1 (GPR30) Receptor in an Embryonic Mouse Hippocampal Cell Line (mHippoE-18)
por: Evans, Nicholas J., et al.
Publicado: (2016)

Identification of the estrogen receptor GPER in neoplastic and non-neoplastic human testes
por: Rago, Vittoria, et al.
Publicado: (2011)

The activation of G protein-coupled receptor 30 (GPR30) inhibits proliferation of estrogen receptor-negative breast cancer cells in vitro and in vivo
por: Wei, W, et al.
Publicado: (2014)

Expression of the G protein-coupled estrogen receptor (GPER) in endometriosis: a tissue microarray study
por: Samartzis, Nicolas, et al.
Publicado: (2012)

Sex Differences in the Vasodilation Mediated by G Protein-Coupled Estrogen Receptor (GPER) in Hypertensive Rats
por: Delgado, Nathalie Tristão Banhos, et al.
Publicado: (2021)

A relation between osteoclastogenesis inhibition and membrane-type estrogen receptor GPR30
por: Masuhara, Masaaki, et al.
Publicado: (2016)

The positivity of G-protein-coupled receptor-30 (GPR 30), an alternative estrogen receptor is not different between type 1 and type 2 endometrial cancer
por: Wan, Jiayi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_kk88a68e5d3pesiinhq1kj4mt2